Riskpilot← Back to searchSign inGet full accessEndeavour Cells ApS
APSActiveCVR 37244031Strevelinsvej 34Research and experimental development on natural sciences and engineering · NACE 7210Est. 2015— employees
Revenue 2024
DKK -431K
+39% vs 2023
EBITDA margin
100.0%
-39% vs 2023
Equity ratio
99.8%
Financial strength
Net profit 2024
DKK -1,9M
-869% vs 2023
| Revenue | DKK -431K | +39% |
| EBITDA | DKK -431K | -39% |
| Net profit | DKK -1,9M | -869% |
| Total assets | DKK 1,2M | +77% |
| Equity | DKK 1,2M | +95% |
| Employees | — | — |
Legal name
Endeavour Cells ApS
CVR number
37244031
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
19. november 2015
Share capital
DKK 500.000
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er forskning og udvikling af lægemidler samt dermed beslægtet virksomhed.
Address
Strevelinsvej 34
Phone
+4561140218
Email
legal@monjasa.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | -112 | -6 | -9 | -11 | -21 | -14 | -339 | -311 | -431 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -112 | -6 | -9 | -11 | -21 | -14 | -339 | -311 | -431 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -112 | -6 | -9 | -11 | -21 | -14 | -339 | -311 | -431 |
| Net financials | -27 | 138 | -7 | 29 | 0 | 1 | -3 | 38 | -1.538 |
| Profit before tax | -139 | 132 | -15 | 18 | -21 | -13 | -342 | -273 | -1.970 |
| Tax | -20 | -6 | -2 | 28 | -5 | 1 | -110 | -79 | -96 |
| Net profit | -119 | 138 | -13 | -10 | -16 | -14 | -232 | -193 | -1.873 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 59 | 177 | 165 | 165 | 58 | 40 | 831 | 680 | 1.204 |
| Equity | -47 | 91 | 78 | 68 | 52 | 38 | 811 | 617 | 1.201 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 105 | 86 | 87 | 97 | 6 | 2 | 20 | 63 | 3 |
| Total debt | 105 | 86 | 87 | 97 | 6 | 2 | 20 | 63 | 3 |
EBITDA margin
-43120800.0%
This company
15.8%
Market median
-272916556% vs market
20162024
Equity ratio
99.8%
This company
38.2%
Market median
+161% vs market
20162024
Return on equity
-156.0%
This company
18.4%
Market median
-948% vs market
20162024
Net profit margin
-187339500.0%
This company
8.1%
Market median
-2312833433% vs market
20162024
Asset turnover
-0.36×
This company
1.12×
Market median
-132% vs market
20162024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20162024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2015-11-19 – 2016-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JJ Management | Management | 2015 | — | — |
AØ Management | Management | 2021 | — | — |
SS Management | Management | 2016 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2018 | — | — | |
| Board of Directors | 2015 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
MULTIPLE HOLDING ApS | Company | 100.0% | 100.0% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ENDEAVOUR INVEST ApS
Endeavour Cells ApS Board members of Endeavour Cells ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Jacobsen | Management | 0 companies |
| Anders Østergaard | Management | 0 companies |
| Svend Stenberg Mølholt | Management | 0 companies |
| Rasmus Ravnholdt Knudsen | Board of Directors | 0 companies |
| Kenneth Henriks | Board of Directors | 0 companies |